Role of Scavenger Receptor A and CD36 in Diet-Induced Nonalcoholic Steatohepatitis in Hyperlipidemic Mice

Gastroenterology

Volumn 138, Issue 7, 2010, Pages

  Bieghs, Veerle ^a   Wouters, Kristiaan ^a   van Gorp, Patrick J ^a   Gijbels, Marion J J ^a   de Winther, Menno P J ^a   Binder, Christoph J ^b,c   Lütjohann, Dieter ^d   Febbraio, Maria ^e   Moore, Kathryn J ^f   van Bilsen, Marc ^a   Hofker, Marten H ^g   Shiri Sverdlov, Ronit ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF BONN   (Germany)

^e LERNER RESEARCH INSTITUTE   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Fatty Liver; Inflammation; Kupffer Cells; Scavenger Receptors

Indexed keywords

CD36 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SCAVENGER RECEPTOR A; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; FOAM CELL; HYPERLIPIDEMIA; KUPFFER CELL; LIPID OXIDATION; LIVER FIBROSIS; MOUSE; NEUTROPHIL CHEMOTAXIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 77952717393     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.02.051     Document Type: Article

References (44)

1. McCullough A.J. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8 (2004) 521-533
2. Parekh S., and Anania F.A. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology 132 (2007) 2191-2207
3. Matsuzawa N., Takamura T., Kurita S., et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46 (2007) 1392-1403
4. Browning J.D., and Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114 (2004) 147-152
5. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
6. Ruvolo P.P. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol Res 47 (2003) 383-392
7. Summers S.A. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45 (2006) 42-72
8. Wouters K., van Gorp P.J., Bieghs V., et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48 (2008) 474-486
9. Mari M., Caballero F., Colell A., et al. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab 4 (2006) 185-198
10. Vergnes L., Phan J., Strauss M., et al. Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J Biol Chem 278 (2003) 42774-42784
11. Yoshimatsu M., Terasaki Y., Sakashita N., et al. Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process. Int J Exp Pathol 85 (2004) 335-343
12. Sano J., Shirakura S., Oda S., et al. Foam cells generated by a combination of hyperglycemia and hyperlipemia in rats. Pathol Int 54 (2004) 904-913
13. Naito M., Kodama T., Matsumoto A., et al. Tissue distribution, intracellular localization, and in vitro expression of bovine macrophage scavenger receptors. Am J Pathol 139 (1991) 1411-1423
14. Kunjathoor V.V., Febbraio M., Podrez E.A., et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 277 (2002) 49982-49988
15. Suzuki H., Kurihara Y., Takeya M., et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386 (1997) 292-296
16. Moore K.J., and Freeman M.W. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 26 (2006) 1702-1711
17. Rahaman S.O., Lennon D.J., Febbraio M., et al. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab 4 (2006) 211-221
18. Moore K.J., Kunjathoor V.V., Koehn S.L., et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest 115 (2005) 2192-2201
19. Manning-Tobin J.J., Moore K.J., Seimon T.A., et al. Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler Thromb Vasc Biol 29 (2008) 19-26
20. Chou M.Y., Fogelstrand L., Hartvigsen K., et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 119 (2009) 1335-1349
21. Karvonen J., Paivansalo M., Kesaniemi Y.A., et al. Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 108 (2003) 2107-2112
22. Horkko S., Bird D.A., Miller E., et al. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 103 (1999) 117-128
23. Platt N., Suzuki H., Kurihara Y., et al. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc Natl Acad Sci U S A 93 (1996) 12456-12460
24. Febbraio M., Hajjar D.P., and Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108 (2001) 785-791
25. Cotena A., Gordon S., and Platt N. The class A macrophage scavenger receptor attenuates CXC chemokine production and the early infiltration of neutrophils in sterile peritonitis. J Immunol 173 (2004) 6427-6432
26. Kuchibhotla S., Vanegas D., Kennedy D.J., et al. Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II. Cardiovasc Res 78 (2008) 185-196
27. Stewart C.R., Stuart L.M., Wilkinson K., et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11 (2010) 155-161
28. Hoebe K., Georgel P., Rutschmann S., et al. CD36 is a sensor of diacylglycerides. Nature 433 (2005) 523-527
29. Triantafilou M., Gamper F.G., Lepper P.M., et al. Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells. Cell Microbiol 9 (2007) 2030-2039
30. Stuart L.M., Deng J., Silver J.M., et al. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J Cell Biol 170 (2005) 477-485
31. Rath P.C., and Aggarwal B.B. TNF-induced signaling in apoptosis. J Clin Immunol 19 (1999) 350-364
32. Canbay A., Kip S.N., Kahraman A., et al. Apoptosis and fibrosis in non-alcoholic fatty liver disease. Turk J Gastroenterol 16 (2005) 1-6
33. Maher J.J., Scott M.K., Saito J.M., et al. Adenovirus-mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis. Hepatology 25 (1997) 624-630
34. Lauber K., Bohn E., Krober S.M., et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113 (2003) 717-730
35. Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol 27 (2002) 23-27
36. Lawson J.A., Fisher M.A., Simmons C.A., et al. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury. Hepatology 28 (1998) 761-767
37. Gervois P., Vu-Dac N., Kleemann R., et al. Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. J Biol Chem 276 (2001) 33471-33477
38. Kruth H.S., Jones N.L., Huang W., et al. Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low-density lipoprotein. J Biol Chem 280 (2005) 2352-2360
39. Kruth H.S., Huang W., Ishii I., et al. Macrophage foam cell formation with native low-density lipoprotein. J Biol Chem 277 (2002) 34573-34580
40. Podrez E.A., Schmitt D., Hoff H.F., et al. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest 103 (1999) 1547-1560
41. Occhino G.I.A., Hietala J., Sutti S., et al. ESBRA 2007. Abstracts of the 11th Congress of the European Society for Biomedical Research on Alcoholism, 23-26 September, Berlin, Germany. Alcohol Suppl 42 (2007) i1-i66
42. Albano E., Mottaran E., Vidali M., et al. Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut 54 (2005) 987-993
43. Tsimikas S., Brilakis E.S., Lennon R.J., et al. Relationship of IgG and IgM autoantibodies to oxidized low-density lipoprotein with coronary artery disease and cardiovascular events. J Lipid Res 48 (2007) 425-433
44. Hulthe J., Wiklund O., Hurt-Camejo E., et al. Antibodies to oxidized LDL in relation to carotid atherosclerosis, cell adhesion molecules, and phospholipase A(2). Arterioscler Thromb Vasc Biol 21 (2001) 269-274